For healthcare providers especially pharmacists, nurses and physicians, we work to provide current information on drug updates, changes in the marketplace, and hot topics in the pharmacy industry.
Episode 46 - Zokinvy and Banlamivimab
In today's episode we’ll discuss the approval of Zokinvy for Hutchinson-Gilford progeria syndrome, and an EUA for banlamivimab, a monoclonal antibody treatment for COVID19. As always feel free to skip around, I'm going to including times in the show notes so you can get the drugs that interest you. Don't forget to like, share, and subscribe! Enjoy!
Episode 45 - Veklury & Inmazeb
We’ll discuss just two things this week - the big item is the approval of Veklury as a treatment for COVID19 and also the approval of Inmazeb, the first treatment for Ebola infection. Don't forget to like, share, and subscribe! Enjoy!
Episode 44 - Opdivo, Nucala, & Xeljanz
We don’t have any new products on the market to talk about, but we are going to discuss the approval of the combination Opdivo and Yervoy for treating mesothelioma, and new indication approvals for Nucala and Xeljanz. We'll also talk about a new age group for Kalydeco for treating cystic fibrosis. Don't forget to like, share, and subscribe! Enjoy!
Episode 43 - Gavreto, Qdolo, & Trulicity
In today's episode, we’re going to talk about the approval of Gavreto, a new gene specific treatment for non-small cell lung cancer, and approval of Qdolo a new oral solution for pain management. We’ll also be discussing approval of new dosing guidelines for Trulicity which will also prompt new strengths available on the market. Don't forget to like, share, and subscribe! Enjoy!
Episode 42 - Enspryng, Onureg, & Sogroya
In todays episode were going to talk about the approval of Enspryng for adult patients with NMOSD, and approval of Onureg for acute myeloid leukemia. Well also talk about Winlevi, a new treatment for acne and approval of Sogroya a once-weekly treatment for adults with growth hormone deficiency.Don't forget to like, share and subscribe! Enjoy!
Episode 41 - Monjuvi, Evrysdi, & Viltepso
In today's episode were going to talk about the approval of Monjuvi for B-cell lymphoma, Lampit for Chagas Disease, and Evrysdi for spinal muscular atrophy. We also have approval of Blenrep for multiple myeloma, and Viltepso for Duchenne Muscular Dystrophy. Don't forget to like, share and subscribe! Enjoy!
Customer ReviewsSee All
These Podcasts are invaluable. I love how you cut to the chase both on the clinical data and the economic impact. Keep up the great work!!!